My Portfolio

Johnson & Johnson JNJ:NYSE

RT Quote | Last NYSE, VOL From CTA | USD

Last | 3:12 PM EDT

223.78

+0.89 (+0.40%)

Volume

3,326,746

52 week range

149.04 - 251.71

Open222.45
Day High224.93
Day Low222.00
Prev Close222.89
52 Week High251.71
52 Week High Date03/02/26
52 Week Low149.04
52 Week Low Date06/20/25

Latest On Johnson & Johnson

Jim Cramer looks at stocks that will go higher if tech retreats20 Hours AgoCNBC.com
TRADE ALERTWe're picking up more shares of an out-of-favor stock with a bright future June 1, 2026CNBC.com
2026 ASCO Annual Meeting: BofA's Jason Gerberry on what to expectJune 1, 2026CNBC.com
Nvidia, Meta and SLB rank among top companies in adopting AI, study saysJune 1, 2026CNBC.com
Here are the 4 big things we're watching in the stock market in the week aheadMay 31, 2026CNBC.com
Jim Cramer looks ahead to next week's market game planMay 29, 2026CNBC.com
J&J CEO Joaquin Duato: It's our mission to become the number 1 company in oncology by 2030May 29, 2026CNBC.com
Watch CNBC's full interview with Johnson & Johnson Chairman and CEO Joaquin DuatoMay 29, 2026CNBC.com
Friday's big stock stories: What’s likely to move the market in the next sessionMay 28, 2026CNBC.com
Here’s our monthly update on all 33 portfolio stocks, including 4 to buy right nowMay 27, 2026CNBC.com

Key Stats

Market Cap538.687B
Shares Out2.41B
10 Day Average Volume7.50M
Dividend5.36
Dividend Yield2.40%
Beta0.26

Latest On Johnson & Johnson

Jim Cramer looks at stocks that will go higher if tech retreats20 Hours AgoCNBC.com
TRADE ALERTWe're picking up more shares of an out-of-favor stock with a bright future June 1, 2026CNBC.com
2026 ASCO Annual Meeting: BofA's Jason Gerberry on what to expectJune 1, 2026CNBC.com
Nvidia, Meta and SLB rank among top companies in adopting AI, study saysJune 1, 2026CNBC.com
Here are the 4 big things we're watching in the stock market in the week aheadMay 31, 2026CNBC.com
Jim Cramer looks ahead to next week's market game planMay 29, 2026CNBC.com
J&J CEO Joaquin Duato: It's our mission to become the number 1 company in oncology by 2030May 29, 2026CNBC.com
Watch CNBC's full interview with Johnson & Johnson Chairman and CEO Joaquin DuatoMay 29, 2026CNBC.com
Friday's big stock stories: What’s likely to move the market in the next sessionMay 28, 2026CNBC.com
Here’s our monthly update on all 33 portfolio stocks, including 4 to buy right nowMay 27, 2026CNBC.com

KEY STATS

Open222.45
Day High224.93
Day Low222.00
Prev Close222.89
52 Week High251.71
52 Week High Date03/02/26
52 Week Low149.04
52 Week Low Date06/20/25
Market Cap538.687B
Shares Out2.41B
10 Day Average Volume7.50M
Dividend5.36
Dividend Yield2.40%
Beta0.26

RATIOS/PROFITABILITY

EPS (TTM)8.65
P/E (TTM)25.88
Fwd P/E (NTM)18.97
EBITDA (TTM)34.592B
ROE (TTM)26.42%
Revenue (TTM)96.362B
Gross Margin (TTM)67.93%
Net Margin (TTM)21.83%
Debt To Equity (MRQ)67.73%

EVENTS

Earnings Date07/15/2026
Ex Div Date05/26/2026
Div Amount1.34
Split Date-
Split Factor-

Content From Our Affiliates

Medline Stock (MDLN) Rises despite FDA Controversy — Here’s Why9 Hours AgoTipRanks
Johnson & Johnson presents exploratory analyses from DAHLIAS study10 Hours AgoTipRanks
Johnson & Johnson announces nipocalimab met primary endpoint in JASMINE study10 Hours AgoTipRanks
Johnson & Johnson Rival Medline Stock (MDLN) Sinks on FDA Warning over Production Practice24 Hours AgoTipRanks
FDA issues draft guidance to help accelerated cell, gene therapies for patientsJune 2, 2026TipRanks

Profile

Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab)...

Joaquin Duato

Chairman of the Board, Chief Executive Officer

Joseph Wolk

Chief Financial Officer, Executive Vice President

Tim Schmid

Executive Vice President, Worldwide Chairman of MedTech

Elizabeth Forminard

Executive Vice President, Chief Legal Officer

Jennifer Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

Address

One Johnson & Johnson Plaza

New Brunswick, NJ

08933

United States

https://www.jnj.com/